S
Shattuck Labs, Inc. (STTK)
NMS – Real Time Price. Currency in USD
6.44
+0.53 (8.97%)
At close: Jun 26, 2026, 4:00 PM EDT
6.48
+0.04 (0.62%)
After-hours: Jun 26, 2026, 7:20 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.44
+0.53 (8.97%)
At close: Jun 26, 2026, 4:00 PM EDT
6.48
+0.04 (0.62%)
After-hours: Jun 26, 2026, 7:20 PM EDT
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
| Name | Position |
|---|---|
| Dr. Abhinav A. Shukla Ph.D. | Chief Technical Officer |
| Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. | Chief Medical Officer |
| Dr. Taylor H. Schreiber M.D., Ph.D. | Co-Founder, CEO & Director |
| Mr. Andrew R. Neill M.B.A. | Chief Financial Officer |
| Mr. Brad Huckabee | Vice President of Accounting & SEC reporting |
| Ms. Kelli Collin M.S. | Senior Vice President of Quality |
| Date | Type | Document |
|---|---|---|
| 2026-06-11 | 8-K | d163713d8k.htm |
| 2026-06-09 | 8-K | d120796d8k.htm |
| 2026-06-02 | 8-K | d149753d8k.htm |
| 2026-05-07 | 8-K | sttk-20260507.htm |
| 2026-05-07 | 10-Q | sttk-20260331.htm |
| 2026-04-08 | DEFA14A | d143192ddefa14a.htm |
| 2026-04-08 | DEF 14A | d134407ddef14a.htm |
| 2026-03-05 | 8-K | sttk-20260305.htm |
| 2026-03-05 | 10-K | sttk-20251231.htm |
| 2026-02-05 | 8-K | d76999d8k.htm |